Your browser doesn't support javascript.
loading
Life-expectancy changes from 2019 to 22: A case study of Japan using provisional death count.
Munira, Mst S; Okada, Yuta; Nishiura, Hiroshi.
Afiliação
  • Munira MS; Kyoto University School of Public Health, Yoshida-Konoe-cho, Sakyo-ku, Kyoto City 6068501, Japan.
  • Okada Y; Kyoto University School of Public Health, Yoshida-Konoe-cho, Sakyo-ku, Kyoto City 6068501, Japan.
  • Nishiura H; Kyoto University School of Public Health, Yoshida-Konoe-cho, Sakyo-ku, Kyoto City 6068501, Japan. Electronic address: nishiura.hiroshi.5r@kyoto-u.ac.jp.
J Infect Public Health ; 17(1): 119-121, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37995557
Many countries struggled with suppressing the incidence of COVID-19 caused by SARS-CoV-2 Omicron variant (B.1.1.529). As the epidemic size of COVID-19 in 2022 became bigger than earlier years in Japan, the present study aimed to estimate life expectancy at birth at the end of 2022, using provisional death datasets in Aichi and Fukui prefectures. We collected monthly death count from 2019 to the end of 2022, computing the period life table. While the life expectancy at birth in Aichi, 2019 was 84.6 years, it was very slightly extended to 84.7 years in 2020 and 2021, followed by a shortening for nearly 0.4 years in 2022. In Fukui, monotonous extension pattern was seen, i.e., 85.5 years in 2019, 85.6 in 2020, followed by 85.8 and 86.2 years in 2021 and 2022, respectively. Although decades-long trend of extending life expectancy at birth was partly discontinued from 2020 due to the pandemic at the national level, we have shown that the pandemic impact was still small in Japan by the end of 2022. First Omicron wave occurred shortly after primary series vaccination, and even real time booster program was underway during that wave. Different demographic consequences between Aichi and Fukui are explained by differential epidemic sizes prior to vaccination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Expectativa de Vida / COVID-19 Limite: Humans / Newborn País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Expectativa de Vida / COVID-19 Limite: Humans / Newborn País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article